Showing results (1411-1420 of 1,482) with videos related to
Sort By:
Pageof 149
Human Psychopharmacology|May 16, 2012
No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from SiberiaSvetlana A Ivanova, Asmar F Y Al Hadithy, Natalia Brazovskaya, et al.Human Psychopharmacology|December 22, 2007
Neurological complications of psychiatric drugs: clinical features and managementPeter M Haddad, Serdar M DursunHuman Psychopharmacology|December 22, 2007
Fatal toxicity of drugs used in psychiatryRobert J FlanaganHuman Psychopharmacology|April 8, 2014
Concurrent tobacco and khat use is associated with blunted cardiovascular stress response and enhanced negative mood: a cross-sectional investigationMustafa al'Absi, Motohiro Nakajima, Anisa Dokam, et al.Human Psychopharmacology|May 15, 2008
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studiesJonathan Davidson, Christer Allgulander, Mark H Pollack, et al.Human Psychopharmacology|April 17, 2014
Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective studyMengxin Wang, Ruihua Hou, Jia Jian, et al.Human Psychopharmacology|April 22, 2008
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholicsG Martinotti, S Andreoli, M Di Nicola, et al.Human Psychopharmacology|April 26, 2008
Is major depressive disorder a metabolic encephalopathy?Brian H HarveyHuman Psychopharmacology|April 17, 2014
Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gainSarah A Gagliano, Arun K Tiwari, Natalie Freeman, et al.Human Psychopharmacology|March 20, 2008
Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopicloneJulia Boyle, Leanne Trick, Sigurd Johnsen, et al.Pageof 149